CAS 156161-89-6
:B Q-788
Descrizione:
B Q-788, identificato dal suo numero CAS 156161-89-6, è un composto chimico che ha attirato l'attenzione nel campo della chimica medicinale, in particolare per le sue potenziali applicazioni terapeutiche. È caratterizzato come un antagonista selettivo di alcuni recettori, il che può contribuire ai suoi effetti farmacologici. Il composto è tipicamente studiato per il suo ruolo nella modulazione delle vie biologiche, influenzando potenzialmente condizioni legate alla salute cardiovascolare e ad altri processi fisiologici. La sua struttura molecolare include gruppi funzionali specifici che migliorano la sua affinità di legame e selettività per i recettori target. Inoltre, la solubilità, stabilità e biodisponibilità di B Q-788 sono fattori importanti che influenzano la sua efficacia e profilo di sicurezza in contesti di ricerca. Come molti composti in questa categoria, studi in corso mirano a chiarire il suo meccanismo d'azione, potenziale terapeutico e eventuali effetti collaterali associati, contribuendo a una migliore comprensione del suo ruolo nello sviluppo di farmaci e nelle applicazioni cliniche.
Formula:C34H50N5O7·Na
InChI:InChI=1/C34H51N5O7.Na/c1-8-9-16-25(31(42)43)35-29(40)26(18-23-20-38(33(45)46-7)28-17-11-10-15-24(23)28)36-30(41)27(19-34(4,5)6)37-32(44)39-21(2)13-12-14-22(39)3;/h10-11,15,17,20-22,25-27H,8-9,12-14,16,18-19H2,1-7H3,(H,35,40)(H,36,41)(H,37,44)(H,42,43);/q;+1/p-1/t21-,22+,25-,26-,27+;/m1./s1
InChI key:InChIKey=IASLQTYUGYPLFB-FUKQNADPSA-N
SMILES:C([C@@H](NC([C@@H](NC(=O)N1[C@@H](C)CCC[C@H]1C)CC(C)(C)C)=O)C(N[C@H](CCCC)C(O)=O)=O)C=2C=3C(N(C(OC)=O)C2)=CC=CC3.[Na]
Sinonimi:- <span class="text-smallcaps">D</smallcap>-Norleucine, N-[(cis-2,6-dimethyl-1-piperidinyl)carbonyl]-4-methyl-<smallcap>L</smallcap>-leucyl-1-(methoxycarbonyl)-<smallcap>D</span>-tryptophyl-, monosodium salt
- <span class="text-smallcaps">D</smallcap>-Norleucine, N-[N-[N-[(2,6-dimethyl-1-piperidinyl)carbonyl]-4-methyl-<smallcap>L</smallcap>-leucyl]-1-(methoxycarbonyl)-<smallcap>D</span>-tryptophyl]-, monosodium salt, cis-
- <span class="text-smallcaps">D</smallcap>-Norleucine, N-[[(2R,6S)-2,6-dimethyl-1-piperidinyl]carbonyl]-4-methyl-<smallcap>L</smallcap>-leucyl-1-(methoxycarbonyl)-<smallcap>D</span>-tryptophyl-, monosodium salt
- <span class="text-smallcaps">D</smallcap>-Norleucine, N-[[(2R,6S)-2,6-dimethyl-1-piperidinyl]carbonyl]-4-methyl-<smallcap>L</smallcap>-leucyl-1-(methoxycarbonyl)-<smallcap>D</span>-tryptophyl-, sodium salt (1:1)
- BQ-788, Sodium Salt
- Bq 788
- sodium (2R)-2-{[(2S)-2-({[(2R,6S)-2,6-dimethylpiperidin-1-yl]carbonyl}amino)-4,4-dimethylpentanoyl][1-(methoxycarbonyl)-D-tryptophyl]amino}hexanoate
- sodium N-{[(2R,6S)-2,6-dimethylpiperidin-1-yl]carbonyl}-4-methyl-L-leucyl-N-[(1R)-1-carboxylatopentyl]-1-(methoxycarbonyl)-D-tryptophanamide
- D-Norleucine, N-[(cis-2,6-dimethyl-1-piperidinyl)carbonyl]-4-methyl-L-leucyl-1-(methoxycarbonyl)-D-tryptophyl-, monosodium salt
- D-Norleucine, N-[[(2R,6S)-2,6-dimethyl-1-piperidinyl]carbonyl]-4-methyl-L-leucyl-1-(methoxycarbonyl)-D-tryptophyl-, sodium salt (1:1)
- D-Norleucine, N-[N-[N-[(2,6-dimethyl-1-piperidinyl)carbonyl]-4-methyl-L-leucyl]-1-(methoxycarbonyl)-D-tryptophyl]-, monosodium salt, cis-
- D-Norleucine, N-[[(2R,6S)-2,6-dimethyl-1-piperidinyl]carbonyl]-4-methyl-L-leucyl-1-(methoxycarbonyl)-D-tryptophyl-, monosodium salt
- sodium,(2R)-2-[[(2R)-2-amino-3-(1-methoxycarbonylindol-3-yl)propanoyl]-[(2S)-2-[[(2R,6S)-2,6-dimethylpiperidine-1-carbonyl]amino]-4,4-dimethylpentanoyl]amino]hexanoate
- BQ-788 SYNTHETIC >97% ETB ENDOTHELIN REC EPT
- N-[N-[N-[(2,6-Dimethyl-1-piperidinyl)carbonyl]-
- 2,6-Dimethylpiperidinecarbonyl-γ-Methyl-Leu-Nin-(Methoxycarbonyl)-D-Trp-D-Nle
- N-cis-2,6-dimethylpiperidinocarbonyl-L-γMeLeu-D-Trp(COOMe)-D-Nle-ONa
- BQ788 SODIUM SALT; BQ 788 SODIUM SALT
- DMpc-gaMMa-MeLeu-D-Trp(1-CO2CH3)-D-Nle.Na (DMpc : cis-2,6-DiMethylpiperidinocarbonyl)
- N-[(cis-2,6-Dimethyl-1-piperidinyl)carbonyl]-4-methyl-L-leucyl-1-(methoxycarbonyl)-D-tryptophyl-D-norleucinesodiumsalt
- N-[N-[N-[(2,6-Dimethyl-1-piperidinyl)carbonyl]-4-methyl-L-leucyl]-1-(methoxycarbonyl)-D-tryptophyl]-D-norleucine sodium salt, 2,6-Dimethylpiperidinecarbonyl-γ-Methyl-Leu-Nin-(Methoxycarbonyl)-D-Trp-D-Nle
- BQ789 Sodium Salt
- N-[N-[N-[(2,6-Dimethyl-1-piperidinyl)carbonyl]-4-methyl-L-leucyl]-1-(methoxycarbonyl)-D-tryptophyl]-D-norleucine sodium salt
- 1-ELAIDYLPHOSPHOCHOLINE, >97%
- BQ-788 SODIUM
- Vedi altri sinonimi
Ordinare per
Purezza (%)
0
100
|
0
|
50
|
90
|
95
|
100
7 prodotti.
Ref: IN-DA001OKH
1mg144,00€5mg303,00€10mg684,00€25mgPrezzo su richiesta50mgPrezzo su richiesta100mgPrezzo su richiestaSodium (R)-2-((R)-2-((S)-2-((2R,6S)-2,6-dimethylpiperidine-1-carboxamido)-4,4-dimethylpentanamido)-3-(1-(methoxycarbonyl)-1H-indol-3-yl)propanamido)hexanoate
CAS:Sodium (R)-2-((R)-2-((S)-2-((2R,6S)-2,6-dimethylpiperidine-1-carboxamido)-4,4-dimethylpentanamido)-3-(1-(methoxycarbonyl)-1H-indol-3-yl)propanamido)hexanoatePurezza:98%Peso molecolare:663.79g/molBQ-788 sodium salt
CAS:BQ-788 sodium salt is a potent and selective antagonist of ETB receptor(ETB receptors with an IC50 of 1.2 nM in human Girrardi heart cells).Formula:C34H51N5NaO7Colore e forma:SolidPeso molecolare:664.8BQ 788
CAS:<p>Applications BQ 788 is an endothelin type B (ETB) receptor antagonist and is a potential antidote for the cardiovascular toxicity with hypotension and bradycardia.<br>References Arici, M.A.A., et. al.: Hum. Exp. Toxicol., 32, 316 (2013)<br></p>Formula:C34H50N5O7·NaColore e forma:NeatPeso molecolare:663.78





